Life Technologies Corporation

Life Technologies Corporation, operating as Thermofisher Scientific, manufactures and supplies laboratory instrumentation, reagents, and consumables to federal agencies as a prime contractor across 172 federal customer agencies without SBA set-aside certifications. The company competes full-and-open across its federal footprint, with a portfolio anchored in genetic analyzers, real-time PCR systems, flow cytometry equipment, nucleic acid extraction instruments, and associated consumables including PCR kits, reagent assays, BigDye Terminator sequencing reagents, and diagnostic test kits supporting federal research, medical, forensic, and environmental missions.

Life Technologies is a subsidiary of Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, with Life Technologies Corporation operations in Carlsbad, California. The corporate structure includes nine named subsidiaries spanning Invitrogen Federal Systems, Applied Biosystems LLC, Molecular Probes Inc., Ion Torrent Systems Incorporated, and others, each carrying distinct capability framing in molecular biology, sequencing, cell imaging, and diagnostic reagent supply. The vendor operates as a pure prime contractor—99.96% of recent awards are prime contracts and IDVs, with minimal subcontracting; across SCI-reportable federal service contracts, the vendor demonstrates zero subcontractor hours share, delivering its own technical teams directly to federal customers.

Customer concentration sits with the National Institutes of Health and the Department of Defense medical commands. The top five customer agencies by award count—NIH Office of the Director (1,434 awards, $10.8 million combined potential value), NIH National Institute of Allergy and Infectious Diseases (518 awards, $12.3 million), NIH National Institute of Environmental Health Sciences (483 awards, $18.5 million), CDC Office of Acquisition Services (408 awards, $10.1 million), and CDC Pittsburgh (392 awards, $70.1 million)—account for 21% of recent awards. By potential value, the distribution diverges: the Department of Army Medical Command anchors $83 million combined potential (168 awards), followed by CDC Pittsburgh ($70.1 million, 392 awards), the Army Criminal Investigation Command ($53.5 million, 258 awards), USDA Agricultural Research Service ($28.6 million, 283 awards), and NIH National Institute of Environmental Health Sciences ($18.5 million, 483 awards), reflecting a 21% coverage of combined potential value. This split signals Army medical operations and criminal investigation forensic work represent the largest dollar concentration, while NIH conducts the highest award volume.

Life Technologies' parent vehicles include a two-thousand-task-order Blanket Purchase Agreement (HHSN263201200063B, $23.8 million combined potential) with the NIH/HHS, a thirteen-hundred-task-order BPA (HHSN263200200056213B, $4 million) also with HHS, a 366-task-order Indefinite Delivery Contract (AG32SDC150056, $7 million) with the Department of Agriculture, a 265-task-order USDA-wide IDIQ (1232SA21D0001, $23.3 million) for OEM service and maintenance agreements covering QuantStudio PCR systems and related instruments across Forest Service and USDA agencies, and a 152-task-order HHS BPA (HHSD2002017M94460B, $10.7 million). A single-award $2.4 million BPA with the Bureau of Alcohol, Tobacco, Firearms and Explosives through May 2031 covers forensic DNA analysis reagents and supplies. A single-award $83.2 thousand IDIQ with Veterans Integrated Service Network 16 through September 2030 covers genetic analyzer maintenance. Recent activity includes a $9.8 million option-year-three funding document for consumables and reagents from the Department of Health and Human Services Headquarters Division (ultimate completion August 2026) and a $21.5 million option-year-three funding document for consumables and reagents from HHS Headquarters (ultimate completion August 2026), signaling multi-year standing agreements with large ceiling values renewed through option periods.

Representative recent prime work spans instruments, consumables, and maintenance across federal labs. Applied Biosystems QuantStudio PCR systems dominate the portfolio: a $29.7 thousand purchase order from Veterans Integrated Service Network 17 for an Applied Biosystems QuantStudio 7 Pro real-time PCR instrument (awarded October 2026, completion October 2030); a $54.6 thousand delivery order from a Midwest Area civilian agency for a QuantStudio 5 PCR System (awarded September 2026, completion November 2026); a $48.6 thousand purchase order from USGS for a QuantStudio 5 384-well system (awarded August 2026, completion October 2026). Imaging systems include a $42.4 thousand purchase order from the National Institute of Environmental Health Sciences for a Thermo Fisher Scientific EVOS M5000 imaging system (awarded September 2026, completion September 2027); a $69.9 thousand purchase order from NIEHs for an Invitrogen EVOS M7000 cell imaging system (awarded September 2026, completion December 2026); a $40 thousand delivery order from a Southeast Area civilian agency for an Invitrogen iBright FL1500 Imaging System (awarded July 2025, completion December 2025). Genetic analysis instruments include a $350 thousand purchase order from the National Cancer Institute for an Attune Xenith Flow Cytometer (awarded September 2026, completion August 2027); a $350 thousand purchase order from the National Institute of Diabetes and Digestive and Kidney Diseases for a flow cytometer (awarded September 2025, completion January 2026). Nucleic acid extraction systems include a $29.5 thousand delivery order from a Midwest Area civilian agency for an automated magnetic nucleic acid extraction instrument supporting M. mycoides research (awarded September 2026, completion October 2026); a $180.2 thousand delivery order from USDA Marketing and Regulatory Programs for a Kingfischer Apex96DW system (awarded September 2026, completion November 2026). Consumables and reagents include a $1.57 billion BPA call from the Defense Health Agency for Life Technologies reagents (awarded June 2026, completion June 2026); a $609.3 thousand BPA call from the Defense Health Agency for reagents and consumables (awarded February 2026, completion February 2026); a $296.1 thousand delivery order from USDA Veterinary Services for MAGMAX Core Nucleic Acid Purification Kits (awarded February 2026, completion May 2026, and again November 2025, completion December 2025, and August 2025, completion August 2025). Maintenance services include a $90.2 thousand purchase order from EPA Office of the Administrator for QuantStudio 5 instrument service and maintenance (awarded September 2026, completion September 2031); a $282.7 thousand purchase order from the Fish and Wildlife Service Region 7 for OEM maintenance, repair, and technical support of eight Life Technologies instruments at the Conservation Genetics Laboratory in Anchorage, Alaska (awarded August 2026, completion July 2029); a $232.4 thousand purchase order from the FDA for ABI 7500 FAST Real-Time PCR System preventative maintenance (awarded September 2025, completion September 2030).

Activity has declined year over year—359 awards in 2022, 301 in 2023, 325 in 2024, 196 in 2025, and 102 in 2026 (partial year)—suggesting either portfolio contraction or a shift away from granular purchase-order reporting toward larger umbrella task orders under existing vehicles. Combined potential value across all awards sits at $1.23 billion, with $677 million (55%) obligated. One hundred thirty-three awards carrying $28.4 million combined potential value reach ultimate completion within the next twenty-four months and face recompete exposure.

SCI-reportable federal service contracts above the $150,000 threshold show minimal invoicing: $3.6 million across prime records from FY2022–FY2025 (FY2022: $1.4 million, 0.6 FTEs; FY2023: $1.8 million, 1.0 FTEs; FY2024: zero; FY2025: $322 thousand, 0.2 FTEs), reflecting that Life Technologies' federal footprint consists predominantly of goods, equipment, and task orders below the SCI reporting threshold rather than service contracts above it. Government-paid hourly rates on SCI service work run around $1,070/hr median, with senior labor pricing reaching $2,009/hr at the 90th percentile, and junior work at $787/hr (10th percentile). The company maintains no sub-engagement on its federal service contracts—zero average subcontractor hours share—delivering all labor with its own staff.

Life Technologies competes without SBA certifications across its entire federal portfolio, relying on open competitive awards and its established position as an original equipment manufacturer and consumables supplier. The vendor supplies federal agencies across 172 distinct customer organizations with laboratory infrastructure critical to biomedical research, disease surveillance, forensic DNA analysis, veterinary diagnostics, and environmental monitoring missions.